Skip to main content

Advertisement

SpringerLink
Log in

Psoriatic arthritis epidemiology

  • Published:
Current Rheumatology Reports Aims and scope Submit manuscript

Abstract

Recent studies have added to our knowledge of the epidemiology of psoriatic arthritis (PsA) across various populations. Absence of a standard case definition and the relative rarity of PsA may have contributed to the paucity of available data to date. Reported prevalence estimates appear to vary more than incidence estimates. Prevalence estimates may vary as a result of differences in genetic factors, exposure to environmental factors, and study methods. Although prevalence data among different subgroups and extrapolation from clinical and laboratory data allow some inferences about the role of various potential risk factors for PsA, only one study has investigated them specifically. Overall, quality of life in PsA appears similar to that in rheumatoid arthritis, whereas available data on the mortality impact of PsA are conflicting, preventing a unified conclusion. This review summarizes recent data on PsA epidemiology.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References and Recommended Reading

  1. Mease P: Psoriatic arthritis update. Bull NYU Hosp Jt Dis 2006, 64:25–31.

    PubMed  Google Scholar 

  2. Kruithof E, Baeten D, De Rycke L, et al.: Synovial histopathology of psoriatic arthritis, both oligo-and polyarticular, resembles spondyloarthropathy more than it does rheumatoid arthritis. Arthritis Res Ther 2005, 7:R569–580.

    Article  PubMed  CAS  Google Scholar 

  3. Gladman DD, Antoni C, Mease P, et al.: Psoriatic arthritis: epidemiology, clinical features, course, and outcome. Ann Rheum Dis 2005, 64(Suppl 2):ii14–17.

    Article  PubMed  Google Scholar 

  4. Henseler T: The genetics of psoriasis. J Am Acad Dermatol 1997, 37:S1–11.

    PubMed  CAS  Google Scholar 

  5. Naldi L: Epidemiology of psoriasis. Curr Drug Targets Inflamm Allergy 2004, 3:121–128.

    Article  PubMed  CAS  Google Scholar 

  6. Gelfand JM, Stern RS, Nijsten T, et al.: The prevalence of psoriasis in African Americans: results from a population-based study. J Am Acad Dermatol 2005, 52:23–26.

    Article  PubMed  Google Scholar 

  7. Taylor W, Gladman D, Helliwell P, et al.: Classification criteria for psoriatic arthritis: development of new criteria from a large international study. Arthritis Rheum 2006, 54:2665–2673.

    Article  PubMed  Google Scholar 

  8. Alenius GM, Stenberg B, Stenlund H, et al.: Inflammatory joint manifestations are prevalent in psoriasis: prevalence study of joint and axial involvement in psoriatic patients, and evaluation of a psoriatic and arthritic questionnaire. J Rheumatol 2002, 29:2577–2582.

    PubMed  Google Scholar 

  9. Harrison BJ, Silman AJ, Barrett EM, et al.: Presence of psoriasis does not influence the presentation or short-term outcome of patients with early inflammatory polyarthritis. J Rheumatol 1997, 24:1744–1749.

    PubMed  CAS  Google Scholar 

  10. Lomholt G: Psoriasis: Prevalence, Spontaneous Course and Genetics: a Census Study on the Prevalence of Skin Diseases on the Faroe Islands. Copenhagen: GEC GAD; 1963.

  11. Hellgren L: Association between rheumatoid arthritis and psoriasis in total populations. Acta Rheumatol Scand 1969, 15:316–326.

    PubMed  CAS  Google Scholar 

  12. van Romunde LK, Valkenburg HA, Swart-Bruinsma W, et al.: Psoriasis and arthritis. I. A population study. Rheumatol Int 1984, 4:55–60.

    Article  PubMed  Google Scholar 

  13. Shbeeb M, Uramoto KM, Gibson LE, et al.: The epidemiology of psoriatic arthritis in Olmsted County, Minnesota, USA, 1982–1991. J Rheumatol 2000, 27:1247–1250.

    PubMed  CAS  Google Scholar 

  14. Alamanos Y, Papadopoulos NG, Voulgari PV, et al.: Epidemiology of psoriatic arthritis in northwest Greece, 1982–2001. J Rheumatol 2003, 30:2641–2644.

    PubMed  Google Scholar 

  15. Trontzas P, Andrianakos A, Miyakis S, et al.: Seronegative spondyloarthropathies in Greece: a population-based study of prevalence, clinical pattern, and management. The ESORDIG study. Clin Rheum 2005, 24:583–589.

    Article  CAS  Google Scholar 

  16. Madland TM, Apalset EM, Johannessen AE, et al.: Prevalence, disease manifestations, and treatment of psoriatic arthritis in Western Norway. J Rheumatol 2005, 32:1918–1922.

    PubMed  Google Scholar 

  17. Gelfand JM, Gladman DD, Mease PJ, et al.: Epidemiology of psoriatic arthritis in the population of the United States. J Am Acad Dermatol 2005, 53:573.

    Article  PubMed  Google Scholar 

  18. Kaipiainen-Seppanen O: Incidence of psoriatic arthritis in Finland. Br J Rheumatol 1996, 35:1289–1291.

    Article  PubMed  CAS  Google Scholar 

  19. Mallbris L, Larsson P, Bergqvist S, et al.: Psoriasis phenotype at disease onset: clinical characterization of 400 adult cases. J Invest Dermatol 2005, 124:499–504.

    Article  PubMed  CAS  Google Scholar 

  20. Solinger AM, Hess EV: Rheumatic diseases and AIDS—is the association real? J Rheumatol 1993, 20:678–683.

    PubMed  CAS  Google Scholar 

  21. Espinoza LR, Jara LJ, Espinoza CG, et al.: There is an association between human immunodeficiency virus infection and spondyloarthropathies. Rheum Dis Clin North Am 1992, 18:257–266.

    PubMed  CAS  Google Scholar 

  22. Njobvu P, McGill P, Kerr H, et al.: Spondyloarthropathy and human immunodeficiency virus infection in Zambia. J Rheumatol 1998, 25:1553–1559.

    PubMed  CAS  Google Scholar 

  23. Njobvu P, McGill P: Psoriatic arthritis and human immunodeficiency virus infection in Zambia. J Rheumatol 2000, 27:1699–1702.

    PubMed  CAS  Google Scholar 

  24. Mijiyawa M, Oniankitan O, Khan MA: Spondyloarthropathies in sub-Saharan Africa. Curr Opin Rheumatol 2000, 12:281–286.

    Article  PubMed  CAS  Google Scholar 

  25. Lopez-Larrea C, Njobvu PD, Gonzalez S, et al.: The HLA-B*5703 allele confers susceptibility to the development of spondylarthropathies in Zambian human immunodeficiency virus-infected patients with slow progression to acquired immunodeficiency syndrome. Arthritis Rheum 2005, 52:275–279.

    Article  PubMed  CAS  Google Scholar 

  26. Scarpa R, Oriente P, Pucino A, et al.: Psoriatic arthritis in psoriatic patients. Br J Rheumatol 1984, 23:246–250.

    Article  PubMed  CAS  Google Scholar 

  27. Jones SM, Armas JB, Cohen MG, et al.: Psoriatic arthritis: outcome of disease subsets and relationship of joint disease to nail and skin disease. Br J Rheumatol 1994, 33:834–839.

    Article  PubMed  CAS  Google Scholar 

  28. Rahman P, Schentag CT, Gladman DD: Immunogenetic profile of patients with psoriatic arthritis varies according to the age at onset of psoriasis. Arthritis Rheum 1999, 42:822–823.

    PubMed  CAS  Google Scholar 

  29. Thumboo J, Uramoto K, Shbeeb MI, et al.: Risk factors for the development of psoriatic arthritis: a population based nested case control study. J Rheumatol 2002, 29:757–762.

    PubMed  Google Scholar 

  30. Zachariae H, Zachariae R, Blomqvist K, et al.: Quality of life and prevalence of arthritis reported by 5,795 members of the Nordic Psoriasis Associations. Data from the Nordic Quality of Life Study. Acta Derm Venereol 2002, 82:108–113.

    Article  PubMed  Google Scholar 

  31. Borman P, Toy GG, Babaoglu S, et al.: A comparative evaluation of quality of life and life satisfaction in patients with psoriatic and rheumatoid arthritis. Clin Rheumatol 2007, 26:330–334.

    Article  PubMed  Google Scholar 

  32. Gelfand JM, Feldman SR, Stern RS, et al.: Determinants of quality of life in patients with psoriasis: a study from the US population. J Am Acad Dermatol 2004, 51:704–708.

    Article  PubMed  Google Scholar 

  33. Sokoll KB, Helliwell PS: Comparison of disability and quality of life in rheumatoid and psoriatic arthritis. J Rheumatol 2001, 28:1842–1846.

    PubMed  CAS  Google Scholar 

  34. Wong K, Gladman DD, Husted J, et al.: Mortality studies in psoriatic arthritis: results from a single outpatient clinic. I. Causes and risk of death. Arthritis Rheum 1997, 40:1868–1872.

    Article  PubMed  CAS  Google Scholar 

  35. Gladman DD, Farewell VT, Wong K, Husted J: Mortality studies in psoriatic arthritis: results from a single outpatient center. II. Prognostic indicators for death. Arthritis Rheum 1998, 41:1103–1110.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Division of Rheumatology, Department of Medicine, University of British Columbia, Arthritis Research Centre of Canada, 895 West 10th Avenue, Vancouver, BC, V5Z 1L7, Canada

    Hyon K. Choi

Authors
  1. Arathi R. Setty
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Hyon K. Choi
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Hyon K. Choi.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Setty, A.R., Choi, H.K. Psoriatic arthritis epidemiology. Curr Rheumatol Rep 9, 449–454 (2007). https://doi.org/10.1007/s11926-007-0073-3

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11926-007-0073-3

Keywords

Search

Navigation